
Monit GTN Controlled Release is a medication used primarily for the management of angina pectoris (chest pain) associated with coronary artery disease. It contains Glyceryl Trinitrate, also known as Nitroglycerin, which works by relaxing the blood vessels, allowing blood to flow more easily to the heart.
Glyceryl Trinitrate is a nitrate that dilates blood vessels, which decreases the workload on the heart and increases the supply of blood and oxygen to the heart muscle. This action helps to relieve the symptoms of angina.
Follow your healthcare provider's instructions regarding the dosage and administration of Monit GTN Controlled Release. It is typically taken orally, and patients should not exceed the recommended dosage.
Some common side effects may include headaches, dizziness, and flushing. Serious side effects are rare but can occur. It is important to consult with a healthcare professional if you experience any unusual symptoms or reactions.
Consult with your healthcare provider before using Monit GTN if you are pregnant or breastfeeding.
Monit GTN may cause dizziness; it is advisable to assess your response to the medication before driving or operating heavy machinery.
Store in a cool, dry place away from direct sunlight and out of reach of children.
Monit GTN Controlled Release is an effective treatment option for individuals suffering from angina pectoris. Always consult your healthcare provider for personalized advice and treatment plans.